Levy D E
Department of Neurology, Cornell University Medical College, New York, NY 10021.
Neurology. 1988 May;38(5):674-7. doi: 10.1212/wnl.38.5.674.
Information on 1,343 hospitalized patients in the Cornell Neurology Database with final diagnoses of transient ischemic attacks (TIA), reversible ischemic neurologic deficits (RIND), or ischemic stroke was examined in order to determine the duration of ischemic deficits. Episodes resolved within the first 24 hours (classic definition of TIA) in 382 of the patients (28.4%) and between days 1 and 7 (consistent with RIND) in 34 (2.5%). In 191 of the 382 patients with traditionally-defined TIAs (50.0%), episodes lasted less than 30 minutes, and in another 37 (9.7%), from 30 to 60 minutes. Of 1,115 patients with deficits lasting at least 60 minutes, only 154 (13.8%) resolved within 24 hours and could thus be considered to have had a TIA. Resolution within the next hour occurred in only 39 of 1,152 patients (3.4%) with a deficit at 30 minutes, 21 of 1,115 patients (1.9%) with a deficit at 60 minutes, 19 of 1,113 patients (1.7%) with a deficit at 90 minutes, and 16 of 1,094 patients (1.5%) with a deficit at 120 minutes. The data suggest that as currently managed, patients with a deficit persisting at least 60 minutes have less than a 2% chance of resolving spontaneously during any subsequent 1-hour period. Rapid resolution after instituting a new treatment in relatively few additional patients would suggest a therapeutic effect, even in a nonrandomized trial.
为了确定缺血性神经功能缺损的持续时间,我们对康奈尔神经病学数据库中1343例最终诊断为短暂性脑缺血发作(TIA)、可逆性缺血性神经功能缺损(RIND)或缺血性卒中的住院患者的信息进行了研究。382例患者(28.4%)的症状在最初24小时内缓解(TIA的经典定义),34例患者(2.5%)的症状在第1天至第7天之间缓解(符合RIND)。在382例传统定义的TIA患者中,191例(50.0%)发作持续时间少于30分钟,另有37例(9.7%)发作持续30至60分钟。在1115例神经功能缺损持续至少60分钟的患者中,只有154例(13.8%)在24小时内缓解,因此可被认为患有TIA。在30分钟时存在神经功能缺损的1152例患者中,只有39例(3.4%)在接下来的1小时内缓解;在60分钟时存在神经功能缺损的1115例患者中,只有21例(1.9%)在接下来的1小时内缓解;在90分钟时存在神经功能缺损的1113例患者中,只有19例(1.7%)在接下来的1小时内缓解;在120分钟时存在神经功能缺损的1094例患者中,只有16例(1.5%)在接下来的1小时内缓解。数据表明,按照目前的治疗方式,神经功能缺损持续至少60分钟的患者在随后任何1小时内自发缓解的几率不到2%。在相对较少的额外患者中采用新治疗方法后迅速缓解,即使在非随机试验中也表明有治疗效果。